Cyclacel Pharma (CYCC) Tops Q2 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ

6. MSFT
7. SPY
8. CRWV
9. SKYD
10. MET

Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

August 10, 2022 4:05 PM EDT

Â - Oral fadraciclib demonstrated good tolerability with continuous dosing;Â anticipate entering Phase 2 POC stage in 2H 2022

Â Â Â Â Â Â Â Â Â - Demonstrated evidence of target engagement for CDK2 and CDK9

Â Â Â Â Â Â Â Â Â - Company to host R&D day in fall of 2022 to highlight data updates Â Â Â Â Â Â Â Â Â for fadraciclib and CYC140 in solid tumor Phase 1/2 studies

Â Â Â Â Â Â Â Â Â - Cash runway into 2H 2023 -

Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â - Conference call scheduled for August 10, 2022 at 4:30 pm... More

Cyclacel Pharma (CYCC) Tops Q2 EPS by 8c

Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

Free News Feed